{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:24:48Z","timestamp":1771529088504,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"LMU Munich\u2019s Institutional Strategy LMU excellent","award":["LMU Munich\u2019s Institutional Strategy LMU excellent"],"award-info":[{"award-number":["LMU Munich\u2019s Institutional Strategy LMU excellent"]}]},{"DOI":"10.13039\/100010447","name":"DZHK","doi-asserted-by":"crossref","award":["DZHK (German Center for Cardiovascular Research)"],"award-info":[{"award-number":["DZHK (German Center for Cardiovascular Research)"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]},{"name":"LMU Munich\u2019s Medical Faculty F\u00f6rderprogramm f\u00fcr Forschung und Lehre","award":["LMU Munich\u2019s Medical Faculty F\u00f6rderprogramm f\u00fcr Forschung und Lehre (F\u00f6FoLe)"],"award-info":[{"award-number":["LMU Munich\u2019s Medical Faculty F\u00f6rderprogramm f\u00fcr Forschung und Lehre (F\u00f6FoLe)"]}]},{"name":"Forschungskommission of the Medical Faculty of the Heinrich Heine University","award":["Forschungskommission of the Medical Faculty of the Heinrich Heine University"],"award-info":[{"award-number":["Forschungskommission of the Medical Faculty of the Heinrich Heine University"]}]},{"name":"Forschungskommission of the Medical Faculty of the Heinrich Heine University","award":["Forschungskommission of the Medical Faculty of the Heinrich Heine University"],"award-info":[{"award-number":["Forschungskommission of the Medical Faculty of the Heinrich Heine University"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11033-019-05003-2","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T18:02:19Z","timestamp":1564423339000},"page":"5695-5702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrin \u00df1 polymorphisms and bleeding risk after coronary artery stenting"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Thienel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00fcsebrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dannenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"7","key":"5003_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494\u2013502","journal-title":"N Engl J Med"},{"issue":"6","key":"5003_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","volume":"4","author":"R Mehran","year":"2001","unstructured":"Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW (2001) Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interven 4(6):654\u2013664","journal-title":"JACC Cardiovasc Interven"},{"issue":"1","key":"5003_CR3","doi-asserted-by":"publisher","first-page":"e000021","DOI":"10.1136\/openhrt-2013-000021","volume":"1","author":"CS Kwok","year":"2014","unstructured":"Kwok CS, Rao SV, Myint PK, Keavney B, Nolan J, Ludman PF, de Belder MA, Loke YK, Mamas MA (2014) Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart 1(1):e000021","journal-title":"Open Heart"},{"key":"5003_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1538-7836.2009.03370.x","volume":"7","author":"B Nieswandt","year":"2009","unstructured":"Nieswandt B, Varga-Szabo D, Elvers M (2009) Integrins in platelet activation. J Thromb Haemost 7:206\u2013209","journal-title":"J Thromb Haemost"},{"issue":"12","key":"5003_CR5","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2003-05-1391","volume":"102","author":"S Gr\u00fcner","year":"2003","unstructured":"Gr\u00fcner S, Prostredna M, Schulte V, Krieg T, Eckes B, Brakebusch C, Nieswandt B (2003) Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102(12):4021\u20134027","journal-title":"Blood"},{"issue":"8","key":"5003_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrm3624","volume":"14","author":"DA Calderwood","year":"2013","unstructured":"Calderwood DA, Campbell ID, Critchley DR (2013) Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol 14(8):503\u2013517","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15","key":"5003_CR7","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1182\/blood-2013-06-508721","volume":"122","author":"T Petzold","year":"2013","unstructured":"Petzold T, Ruppert R, Pandey D, Barocke V, Meyer H, Lorenz M, Zhang L, Siess W, Massberg S, Moser M (2013) Beta1 integrin-mediated signals are required for platelet granule secretion and hemostasis in mouse. Blood 122(15):2723\u20132731","journal-title":"Blood"},{"issue":"3","key":"5003_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa031859","volume":"350","author":"A Kastrati","year":"2004","unstructured":"Kastrati A, Mehilli J, Sch\u00fchlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Bollwein H, Volmer C, Gawaz M, Berger PB, Sch\u00f6mig A (2004) A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350(3):232\u2013238","journal-title":"N Engl J Med"},{"issue":"24","key":"5003_CR9","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1161\/01.CIR.0000148956.93631.4D","volume":"110","author":"J Mehilli","year":"2004","unstructured":"Mehilli J, Kastrati A, Sch\u00fchlen H, Dibra A, Dotzer F, von Beckerath N, Bollwein H, Pache J, Dirschinger J, Berger PP, Sch\u00f6mig A (2004) Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 110(24):3627\u20133635","journal-title":"Circulation"},{"issue":"5","key":"5003_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2796.2004.01398.x","volume":"256","author":"J Hausleiter","year":"2004","unstructured":"Hausleiter J, Kastrati A, Mehilli J, Sch\u00fchlen H, Pache J, Dotzer F, Glatthor C, Siebert S, Dirschinger J, Sch\u00f6mig A (2004) A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med 256(5):388\u2013397","journal-title":"J Intern Med"},{"issue":"13","key":"5003_CR11","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","volume":"295","author":"A Kastrati","year":"2006","unstructured":"Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Sch\u00fchlen H, Dirschinger J, Berger PB, Sch\u00f6mig A (2006) Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295(13):1531\u20131538","journal-title":"JAMA"},{"issue":"7","key":"5003_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJMoa0802944","volume":"359","author":"A Kastrati","year":"2008","unstructured":"Kastrati A, Neumann FJ, Mehilli J, Byrne RA, Iijima R, B\u00fcttner HJ, Khattab AA, Schulz S, Blankenship JC, Pache J, Minners J, Seyfarth M, Graf I, Skelding KA, Dirschinger J, Richardt G, Berger PB, Sch\u00f6mig A (2008) Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 359(7):688\u2013696","journal-title":"N Engl J Med"},{"issue":"20","key":"5003_CR13","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1093\/eurheartj\/ehq330","volume":"31","author":"S Schulz","year":"2010","unstructured":"Schulz S, Mehilli J, Neumann FJ, Schuster T, Massberg S, Valina C, Seyfarth M, Pache J, Laugwitz KL, B\u00fcttner HJ, Ndrepepa G, Sch\u00f6mig A, Kastrati A (2010) ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. Eur Heart J 31(20):2482\u20132491","journal-title":"Eur Heart J"},{"issue":"21","key":"5003_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","volume":"365","author":"A Kastrati","year":"2011","unstructured":"Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M, Laugwitz KL, Pache J, Ott I, Hausleiter J, Seyfarth M, Gick M, Antoniucci D, Sch\u00f6mig A, Berger PB, Mehilli J (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980\u20131989","journal-title":"N Engl J Med"},{"key":"5003_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-61779-166-6_22","volume":"757","author":"CA Lowell","year":"2012","unstructured":"Lowell CA, Mayadas TN (2012) Overview-studying integrins in vivo. Methods Mol Biol 757:369\u2013397","journal-title":"Methods Mol Biol"},{"issue":"9","key":"5003_CR16","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood.V82.9.2693.2693","volume":"82","author":"TJ Kunicki","year":"1993","unstructured":"Kunicki TJ, Orchekowski R, Annis D, Honda Y (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82(9):2693\u20132703","journal-title":"Blood"},{"issue":"6","key":"5003_CR17","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1182\/blood.V89.6.1939","volume":"89","author":"TJ Kunicki","year":"1997","unstructured":"Kunicki TJ, Kritzik M, Annis DS, Nugent DJ (1997) Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89(6):1939\u20131943","journal-title":"Blood"},{"issue":"9150","key":"5003_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(98)06448-4","volume":"353","author":"K Moshfegh","year":"1999","unstructured":"Moshfegh K, Wuillemin WA, Redondo M, L\u00e4mmle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia\/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353(9150):351\u2013354","journal-title":"Lancet"},{"issue":"11","key":"5003_CR19","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1182\/blood.V95.11.3297","volume":"95","author":"N von Beckerath","year":"2000","unstructured":"von Beckerath N, Koch W, Mehilli J, B\u00f6ttiger C, Sch\u00f6mig A, Kastrati A (2000) Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30\u00a0days after coronary artery stenting. Blood 95(11):3297\u20133301","journal-title":"Blood"},{"issue":"8","key":"5003_CR20","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood.V93.8.2449.408k34_2449_2453","volume":"93","author":"S Santoso","year":"1999","unstructured":"Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A (1999) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 93(8):2449\u20132453","journal-title":"Blood"},{"issue":"9511","key":"5003_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","volume":"367","author":"Z Ye","year":"2006","unstructured":"Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367(9511):651\u2013658","journal-title":"Lancet"},{"issue":"49","key":"5003_CR22","first-page":"202","volume":"3","author":"M Sionova","year":"2017","unstructured":"Sionova M, Blasko P, Jirous S, Vindis D, Rokyta R, Motovska Z (2017) Association of polymorphisms of platelet receptors GPIa (807C\u2009>\u2009T), GPVI (13254T\u2009>\u2009C), and P2Y12 (34C\u2009>\u2009T and H1\/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography\/percutaneous coronary intervention. Adv Interv Cardiol 3(49):202\u2013209","journal-title":"Adv Interv Cardiol"},{"issue":"16","key":"5003_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1186\/s12864-015-2328-0","volume":"21","author":"T Huang","year":"2015","unstructured":"Huang T, Shu Y, Cai YD (2015) Genetic differences among ethnic groups. BMC Genomics 21(16):1093","journal-title":"BMC Genomics"},{"issue":"16","key":"5003_CR24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2018.14955","volume":"23","author":"T De","year":"2018","unstructured":"De T, Alarcon C, Hernandez W, Liko I, Cavallari LH, Duarte JD, Perera MA (2018) Association of genetic variants with warfarin-associated bleeding among patients of african descent. JAMA 23(16):1670\u20131677","journal-title":"JAMA"},{"issue":"13","key":"5003_CR25","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.112.001233","volume":"127","author":"G Par\u00e9","year":"2013","unstructured":"Par\u00e9 G, Eriksson N, Lehr T, Connolly S, Eikelboom J, Ezekowitz MD, Axelsson T, Haertter S, Oldgren J, Reilly P, Siegbahn A, Syvanen AC, Wadelius C, Wadelius M, Zimdahl-Gelling H, Yusuf S, Wallentin L (2013) Genetic determinants of dabigatran plasma levels and their relation to bleeding. Circulation 127(13):1404\u20131412","journal-title":"Circulation"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05003-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:19:53Z","timestamp":1595891993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05003-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5003"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05003-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}